Deferasirox
Showing 101 - 114 of 114
Changes in Pituitary Iron and Volume With Deferasirox
Completed
- Iron Overload
-
Los Angeles, CaliforniaChildren's Hospital Los Angeles
Jun 17, 2011
Transfusional Iron Overload in ß-thalassemia Trial in Worldwide (Deferasirox)
Completed
- Transfusional Iron Overload in β-thalassemia
- Deferasirox
-
Los Angeles, California
- +48 more
May 24, 2011
Sickle Cell Disease, Iron Overload, Hemolytic Anemia Trial in Canada, United States (Deferasirox (ICL670), Deferoxamine (DFO))
Completed
- Sickle Cell Disease
- +2 more
- Deferasirox (ICL670)
- Deferoxamine (DFO)
-
Birmingham, Alabama
- +58 more
May 23, 2011
Porphyria Cutanea Tarda Trial in Colombes (Exjade)
Unknown status
- Porphyria Cutanea Tarda
-
Colombes, Ile de France, FranceHopital Louis Mourier, GI unit,
Jan 26, 2011
Thalassemia Trial in New York (Deferoxamine, Deferasirox)
Unknown status
- Thalassemia
- Deferoxamine
- Deferasirox
-
New York, New YorkWeill Cornell Medical Center
Nov 4, 2010
Healthy Trial (Deferasirox)
Completed
- Healthy
- Deferasirox
- (no location specified)
Nov 18, 2009